Cardiovascular safety liabilities of VEGFR-2 inhibitors
The identification of the vascular endothelial growth factor (VEGF) as a crucial determinant in neoangiogenesis, as well as the role of its overexpression in tumour growth and dissemination, have provided an attractive target for more specific cancer treatments. In particular, since the clinical app...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/77254/ |